The role of CD44 has been extensively studied in various tumors, such as intestinal cancer [67,68], breast cancer [69], and ovarian cancer [70], and is closely related to chemotherapeutic drug sensitivity and tumor cell adhesion and migration [70], but there is still a large gap in PAAD. This evidence concerns the gene CD44 and breast carcinoma.